[Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin]. 1983

R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004423 Ear The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE. Vestibulocochlear System,Vestibulocochlear Apparatus,Apparatus, Vestibulocochlear,Ears,System, Vestibulocochlear
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
October 1978, Experientia,
R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
October 1981, Fortschritte der Medizin,
R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
September 1979, La Pediatria,
R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
January 1978, Experimentelle Pathologie,
R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
April 1978, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
December 1973, The American journal of the medical sciences,
R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
August 1972, Archives of disease in childhood,
R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
June 1973, Fogorvosi szemle,
R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
January 1996, Journal of chemotherapy (Florence, Italy),
R Cuena Boy, and J R Azanza Perea, and L M Echeverría Echepare, and J Honorato Pérez
June 1973, Journal of psycholinguistic research,
Copied contents to your clipboard!